Laboratory Assay Optimization 2.0


About this study

The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 on the immune system and potential ways to eliminate the virus(es).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.


 Inclusion Criteria:

  •  HIV positive donors and/or Hepatitis C Virus (HCV) positive and/or recovered SARS-CoV-2 positive adult (≥18 years of age) donors will be recruited for apheresis by the primary investigator, HIV clinic nurses, or clinic phlebotomists.

Exclusion criteria:

  • Inability to provide informed consent,
  • Pregnancy,
  • Inability to obtain peripheral venous access for the apharesis procedure. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Andrew Badley, M.D.

Open for enrollment

More information


Publications are currently not available

Mayo Clinic Footer